News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
Shionogi & Co., Ltd. And Nippon Kayaku Co., Ltd. To Release Cetrotide In Japan
September 21, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Tokyo, Sept 21, 2006 (JCN) - Shionogi & Co., Ltd. and Nippon Kayaku Co., Ltd. today announced the release of Cetrotide (generic name: Cetrorelix acetate), indicated for the prevention of premature ovulation.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Asia
MORE ON THIS TOPIC
Adcomms
AstraZeneca faces uphill battle at upcoming adcomm in face of FDA questions
April 29, 2026
·
3 min read
·
Tristan Manalac
Regulatory
Amgen, AstraZeneca join FDA effort harnessing cloud for real-time clinical trials
April 29, 2026
·
3 min read
·
Tristan Manalac
Podcast
Q1 earnings take off, Lilly strikes many deals, Regeneron notches historic approval, FDA raises questions
April 29, 2026
·
1 min read
·
Heather McKenzie
Regulatory
FDA alleges ‘manipulated’ data supported approval of Amgen’s autoimmune drug
April 28, 2026
·
2 min read
·
Tristan Manalac
